Pramodini Medicare IPO

About Pramodini Medicare Company

Pramodini Medicare, incorporated in September 2000 in Vijayawada and converted to a public limited company in 2025, has evolved from a single diagnostic center into a technology-enabled, multi-state diagnostic services provider operating across radiology, clinical laboratory, and nuclear medicine. Its core business is delivering comprehensive diagnostic testing through hospital-based centers and standalone facilities, with a service portfolio that includes MRI, CT scans, X-ray, ultrasound, mammography, DEXA, PET-CT, SPECT, and a full range of pathology tests in hematology, biochemistry, microbiology, and immunology, supported by 24x7 teleradiology reporting. The company’s expertise lies in structuring and operating diagnostic centers via public-private partnerships (PPP), private-private partnerships, strategic alliances with PSUs, and standalone private centers, enabling it to serve tier I, II, and III cities with standardized protocols and centralized reporting. A notable strength is its diversified partnership model and broad modality coverage, which allow it to cater to government hospitals, private hospitals, medical colleges, and direct patients while maintaining asset-light, scalable operations. Pramodini Medicare’s approach to client engagement emphasizes accessible, high-quality diagnostics, close collaboration with institutional partners, and network expansion to address regional gaps in advanced imaging and laboratory services.